Latest Stories
2 High-Flying Stocks to Keep an Eye On and 1 Facing Challenges
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
3 Reasons to Avoid ANGI and 1 Stock to Buy Instead
Angi has gotten torched over the last six months - since June 2025, its stock price has dropped 28.7% to $12.01 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Consumer Stocks with Warning Signs
Consumer discretionary businesses are levered to the highs and lows of economic cycles. Thankfully for the industry, all signs are pointing up as discretionary stocks have gained 19.1% over the past six months, beating the S&P 500’s 14.1% return.
1 Healthcare Stock with Promising Prospects and 2 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 15.5% return has closely followed the S&P 500.
2 Volatile Stocks with Exciting Potential and 1 We Question
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.
1 Small-Cap Stock with Competitive Advantages and 2 Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
3 Healthcare Stocks We’re Skeptical Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 15.5%, nearly mirrorring the S&P 500.
1 Mid-Cap Stock to Target This Week and 2 We Brush Off
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
1 Bank Stock with Exciting Potential and 2 That Underwhelm
Banks serve as the backbone of the economy, facilitating lending, deposits, and financial services that keep businesses and consumers moving forward. But worries about an economic slowdown and potential credit deterioration have kept sentiment in check, and over the past six months, the banking industry’s 9.7% return has trailed the S&P 500 by 4.4 percentage points.
3 Small-Cap Stocks We Think Twice About
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.